TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities

Benzinga Logo Benzinga By Lekha Gupta
Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities

Thermo Fisher Scientific announced it will acquire Clario Holdings for $8.875 billion in cash, expanding its digital pharmaceutical capabilities and clinical trial data management platform, with the transaction expected to close by mid-2026.

Insights
MS   neutral

Analyst Kristine Liwag maintained a hold recommendation with a reduced price target of $45


TMO   positive

Company is expanding digital capabilities, expects immediate EPS accretion, and anticipates high single-digit business growth with $175 million in synergies